Need more options? Click Here for Advanced Search!

Fatality Blind Spots: How to Identify Human and Organizational Performance Issues and Minimize the Risk of Serious Injuries and Deaths

Fatality Blind Spots: How to Identify Human and Organizational Performance Issues and Minimize the Risk of Serious Injuries and Deaths

Product Code: YSWA102417

* Required Fields

Internet Special:
$149.00
Add Items to Cart

Fatality Blind Spots: How to Identify Human and Organizational Performance Issues and Minimize the Risk of Serious Injuries and Deaths

Live Webinar: Tuesday, October 24, 2017

1:30 p.m. to 3:00 p.m. Eastern/10:30 a.m. to 12:00 p.m. Pacific


WEBINAR SNAPSHOT: Learn how to assess whether your organization has fatality risk blind spots—and where and how to address critical human and organizational performance issues to minimize the risk of serious injuries or deaths.


 

True or false: If you reduce the risk of the most common injuries, you also reduce the risk of all injury types, including serious injuries and fatalities. Additionally, if you reduce your total recordable incident rate (TRIR), you’re also reducing your risk of a serious injury or fatality. 

If you answered “true,” to one or both of these questions, you likely have a fatality risk blind spot. 

The risk factors for serious injuries and fatalities are different from the risk factors for more common, less severe injuries—yet many companies are operating under the incorrect assumption that a single risk assessment process will successfully target both. Even if you’ve reduced your incident rate to near zero, if you’re not actively identifying and managing the fatality risks in your organization, you may have a blind spot that’s a tragedy waiting to happen. To prevent these rare but serious incidents, organizations need to learn approaches for managing their unique risks differently. 

Join us on October 24 for an in-depth webinar when David Eherts, Ph.D, CIH, Vice President of Global EHS at Allergan, will reveal best practices for uncovering and addressing fatality risk blind spots. 

You’ll learn: 

  • How to define “safety” and “good observations,” which correlate to injury rates 
  • Whether getting to “zero” is the right target 
  • How the Heinrich Pyramid works and how incident rates factor into fatality risks 
  • What safety managers can do to tackle “The Iceberg of Ignorance” that can contribute to fatality risks in the workplace 
  • The role of human and organizational performance (HOP) in building error-tolerant defenses—and 6 key principles of HOP every safety manager needs to know 
  • The differences among fragile, stable, and resilient safety systems 
  • How HOP theory has influenced EHS at Allergan—and how to put the same techniques into practice at your company to lower the risk of fatal injuries in the workplace 
  • The role of safety walk-throughs, rules, pre-/post-shift meetings, EHS communication and alerts, and risk maps 

About Your Presenter:

David Eherts, Ph.D., CIHDavid Eherts, Ph.D, CIH 
VP Global EHS 
Allergan 

Dr. David Eherts is the Vice President of Global EHS for Allergan, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products, in March 2014 as Vice President of Global EHS. 

Dr. Eherts has over 30 years of experience in the safety and EHS fields. Dr. Eherts holds Bachelor’s degrees in Chemistry and Biology and a Masters and PhD in Environmental Toxicology from Drexel University. He is an adjunct professor at New York Medical College and at Tulane University where he teaches courses in EHS Management, Environmental Toxicology, Industrial Hygiene and Occupational Health and was recently appointed by the U.S. Secretary of Labor to OSHA’s Federal Whistleblower Protection Advisory Committee. 


Have a specific question related to the topic of this audio conference? Post it here and get an answer during the event, time permitting, or in a follow-up e-mail from the audio conference presenter. This is only available to audio conference registrants.

Ask Question





* Required Fields